Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-019758

Director acquired 115,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Belldegrun Arie Director 2019-03-13 Grant or award +115,333 150,333 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Belldegrun Arie Director 2019-03-13 Grant or award · Stock Option (Right to Buy) +195,133 195,133 D: show line 2 in the form
Loading xslF345X03/doc4.xml…